产品说明书

PT2399

Print
Chemical Structure| 1672662-14-4 同义名 : -
CAS号 : 1672662-14-4
货号 : A1176640
分子式 : C17H10F5NO4S
纯度 : 98%
分子量 : 419.323
MDL号 : MFCD32062659
存储条件:

粉末 Inert atmosphere,Store in freezer, under -20°C

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 190 mg/mL(453.11 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 PT2399 is a potent and selective HIF-2α antagonist that directly binds to the HIF-2α PAS B domain with an IC50 value of 6 nM. PT2399 has shown potent antitumour activity in vivo[1][2][3].PT2399 directly binds to the HIF-2α PAS B domain and impairs the ability of HIF-2α to bind to the aromatic hydrocarbon receptor nuclear transporter (ARNT)[2].At a concentration of 20 μM, PT2399 inhibited the proliferation of HIF-2α -/- 786-O cells and other cancer cell lines in which HIF-2α was undetectable, suggesting that PT2399 leads to off-target toxicity. PT2399 inhibited a variety of HIF-targeted genes in 786-O VHL-/- ccRCC cells, but not HIF-1α-specific target genes such as BNIP3[2].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.38mL

0.48mL

0.24mL

11.92mL

2.38mL

1.19mL

23.85mL

4.77mL

2.38mL

参考文献

[1]Chen W, et al. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature. 2016 Nov 3;539(7627):112-117.

[2]Cho H, et al. On-Target Efficacy of a HIF2α Antagonist in Preclinical Kidney Cancer Models. Nature. Nature. 2016 Nov 3;539(7627):107-111.

[3]Wehn PM, et al. Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1 H-inden-4